The impact of allergic rhinitis on quality of life and other airway diseases. Summary of a European conference.
D000367:Age Factors; D004359:Drug Therapy, Combination; D005260:Female; D006634:Histamine H1 Antagonists / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000737:chemistry / Q000378:metabolism; D008297:Male; D014663:Nasal Decongestants / Q000008:administration & dosage / Q000494:pharmacology; D010353:Patient Education as Topic / Q000639:trends; D011247:Pregnancy; D011788:Quality of Life; D012221:Rhinitis, Allergic, Perennial / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D018434:Sickness Impact Profile
D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D018799:Intercellular Adhesion Molecule-1